Panaceo " MED " for IBS (Irritable Bowel Syndrome)
Conditions:   Irritable Bowel Syndrome;   Microbial Colonization;   Intestinal Disease Intervention:   Other: Zeolite Sponsor:   Scigenia GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: Fibre 1 (combined fibres);   Dietary Supplement: Fibre 2 (natural fibres);   Dietary Supplement: Dietary Supplement: placebo Sponsors:   King's College London;   Guy's and St Thomas' NHS Foundation Trust;   Universidad Veracruzana;   University of Liverpool Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2019 Category: Research Source Type: clinical trials